Accessibility Menu
Axim Biotechnologies logo

Axim Biotechnologies

(OTC) AXIM

Current Price$0.00
Market Cap$1.46M
Since IPO (2013)-93%
5 Year-99%
1 Year-35%
1 Month-29%

Axim Biotechnologies Financials at a Glance

Market Cap

$1.46M

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.05M

EPS (TTM)

-$0.00

P/E Ratio

-1.26

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Price

$0.00

Volume

21,010

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.03

Estimated Earnings Date

Apr 13, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axim Biotechnologies

Industry

Biotechnology

Employees

7

CEO

John W. Huemoeller, II

Headquarters

San Diego, CA 92121, US

AXIM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

31%

Return on Assets

-16%

Earnings Yield

-79.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.46M

Shares Outstanding

340.46M

Volume

21.01K

Avg. Volume

143.32K

Financials (TTM)

Gross Profit

-$427.37K

Operating Income

-$1.32M

EBITDA

-$892.28K

Operating Cash Flow

-$686.21K

Capital Expenditure

$0.00

Free Cash Flow

-$686.21K

Cash & ST Invst.

$4.97K

Total Debt

$7.78M

Axim Biotechnologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$108.13K

-787.2%

Gross Margin

0.00%

N/A

Market Cap

$1.46M

N/A

Market Cap/Employee

$244.00K

N/A

Employees

6

N/A

Net Income

$135.92K

+106.0%

EBITDA

$328.35K

+117.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$2.80K

-53.6%

Total Debt

$7.55M

+17.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.44M

+17.9%

Short Term Debt

$101.55K

-45.2%

Return on Assets

-15.97%

N/A

Return on Invested Capital

31.21%

N/A

Free Cash Flow

-$673.59K

-221.8%

Operating Cash Flow

-$673.59K

-221.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LVVVLiveWire Ergogenics, Inc.
$0.00+0.00%
PKTXProtoKinetix, Incorporated
$0.01+8.08%
SIGYSigyn Therapeutics, Inc.
$0.04-10.26%
REPCFRepliCel Life Sciences Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.49-0.02%
AALAmerican Airlines Group
$15.99+0.04%
PFEPfizer
$25.21-0.03%
FLEXFlex
$147.61+0.03%

Questions About AXIM

What is the current price of Axim Biotechnologies?

Axim Biotechnologies is trading at $0.00 per share.

What is the 52-week range for Axim Biotechnologies?

Over the past 52 weeks, Axim Biotechnologies has traded between $0.00 and $0.03.

How much debt does Axim Biotechnologies have?

As of the most recent reporting period, Axim Biotechnologies reported total debt of $7.60M.

How much cash does Axim Biotechnologies have on hand?

Axim Biotechnologies reported $1.72K in cash and cash equivalents in its most recent financial results.

What is Axim Biotechnologies’s dividend yield?

Axim Biotechnologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.